Leiden, The Netherlands, September 28, 2011 – Dutch biotech company ProteoNic B.V. announces successful completion of a € 6 mln equity financing round led by US-based Fairbanks Investment Fund (FIF), with existing shareholders participating. The funding will be used to accelerate commercialization of ProteoNic’s proprietary UNic™ recombinant protein yield enhancement technology and expand the company’s capabilities in the area of cell line generation and contract services.
March 8, 2011 – Leiden, Netherlands/Oxford, United Kingdom – ProteoNic BV, the protein production experts, and Oxford Expression Technologies Ltd (OET), a leading provider of baculovirus-based protein expression products and services, have joined forces in the field of recombinant protein production technology with the aim of jointly offering a superior platform and services. Several projects combining ProteoNic’s UNic™ translation enhancement elements with OET’s flashBAC™ system have been initiated.
Leiden/Delft, 3 May 2011 – Dutch Life Sciences Company ProteoNic B.V. has joined the Industrial Platform of the Kluyver Centre for Genomics of Industrial Fermentation. Through this membership ProteoNic obtains early access to fundamental research carried out within the Kluyver Centre.